Canadian Medical Association Journal, Vol 156, Issue 2 193-199, Copyright © 1997 by Canadian Medical Association

Review * Synthèse

Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion

J. C. Bailar and B. MacMahon

The authors assess the randomization strategy that had been used in the Canadian National Breast Screening Study (NBSS). Document experts at a private investigation and security company were hired to assist in reviewing instances in which names of subjects were altered in the "allocation books" (the basic instrument used to assign, at random, participants to either the mammography or the usual-care arm). The review was restricted to records from 3 NBSS centres where women assigned to the mammography arm had a distinctly higher (not necessarily significant) number of deaths from breast cancer than those assigned to the usual-care arm, and to records from 2 centres where, for limited periods, administrative problems were reported. In most cases the underlying, original name could be identified. The document experts found no evidence of a deliberate attempt to conceal the alterations. A search of the NBSS database for the underlying and superimposed names revealed that only 1 of the women whose name had been deleted or superimpsed died of breast cancer. She was in the mammography arm. The authors' thorough review of ways in which the randomization could have been subverted failed to uncover credible evidence of it. They conclude that even if there had been acts of subversion, they could only have been few in number and, given that there was only 1 death from breast cancer in the group reviewed, the alterations could have had only a trivial effect on the study findings as reported in 1992.

This article has been cited by other articles:

				D. B. Kopans Bias in the Medical Journals: A Commentary Am. J. Roentgenol., July 1, 2005; 185(1): 176 - 182. [Abstract] [Full Text] [PDF]

				D. A Freedman, D. B Petitti, and J. M Robins On the efficacy of screening for breast cancer Int. J. Epidemiol., February 1, 2004; 33(1): 43 - 55. [Abstract] [Full Text] [PDF]

				P. C Gotzsche On the benefits and harms of screening for breast cancer Int. J. Epidemiol., February 1, 2004; 33(1): 56 - 64. [Full Text] [PDF]

				J. Hoey Mammography screening among women aged 40-49 years shows no benefit Can. Med. Assoc. J., October 15, 2002; 167(8): 898 - 898. [Full Text] [PDF]

				A. B. Miller, T. To, C. J. Baines, and C. Wall The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years Ann Intern Med, September 3, 2002; 137(5_Part_1): 305 - 312. [Abstract] [Full Text] [PDF]

				J. Ringash Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer Can. Med. Assoc. J., February 1, 2001; 164(4): 469 - 476. [Abstract] [Full Text] [PDF]

				A. B. Miller, T. To, C. J. Baines, and C. Wall Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years J Natl Cancer Inst, September 20, 2000; 92(18): 1490 - 1499. [Abstract] [Full Text] [PDF]

				J. Wells, G. J Ong, and H. Bastian Mammography and the politics of randomised controlled trials • Commentary: The public has a role to play in translating evidence into practice • Commentary: Why are researchers surprised when there is not a smooth transition from research into practice? BMJ, October 31, 1998; 317(7167): 1224 - 1230. [Full Text]

HOME	CURRENT ISSUE	PAST ISSUES	COLLECTIONS	HELP	SEARCH
Copyright 1995-1997, Canadian Medical Association. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p) All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.